Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 1;8(9):1354-1356.
doi: 10.1001/jamaoncol.2022.2624.

Incidence of Anaplastic Large-Cell Lymphoma of the Breast in the US, 2000 to 2018

Connor J Kinslow  1 , Arreum Kim  2   3   4 , Gloria I Sanchez  5 , Simon K Cheng  1   4 , Lisa A Kachnic  1   4 , Alfred I Neugut  2   3   4 , David P Horowitz  1   4
Affiliations

Incidence of Anaplastic Large-Cell Lymphoma of the Breast in the US, 2000 to 2018

Connor J Kinslow et al. JAMA Oncol. .

Abstract

This cohort study of data from the Surveillance, Epidemiology, and End Results 18 database examines the incidence of anaplastic large-cell lymphoma of the breast in the US from 2000 to 2018.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Cheng reported receiving personal fees and nonfinancial support from AbbVie outside the submitted work. Dr Kachnic reported receiving royalties from UpToDate, being a member of the Data Safety Monitoring Committee for New Beta Innovation, and performing contracted research for Varian Medical Systems outside the submitted work. Dr Neugut reported receiving consulting fees from Otsuka, GlaxoSmithKline, Eisai, United Biosource, and Hospira; receiving grants from Otsuka; and serving on the medical advisory board of EHE International outside the submitted work. Dr Horowitz reported receiving grant funding from the National Institute of Allergy and Infectious Diseases outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Cumulative Lifetime Risk of Anaplastic Large-Cell Lymphoma (ALCL) of the Breast and ALCL Plus T-Cell Lymphoma Not Otherwise Specified (ALCL/T-NOS)
Cumulative lifetime risks were calculated from crude annual incidence rates.
Figure 2.
Figure 2.. Age-Adjusted Incidence Rate of Anaplastic Large-Cell Lymphoma (ALCL) of the Breast and ALCL Plus T-Cell Lymphoma Not Otherwise Specified (ALCL/T-NOS)
A, The sloped line indicates the linear regression trend for ALCL. B, The incidence rate of ALCL (blue) is superimposed onto ALCL/T-NOS (orange) for reference; the sloped line indicates the linear regression trend for ALCL/T-NOS. Shaded areas indicate 95% CIs.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Quesada AE, Medeiros LJ, Clemens MW, Ferrufino-Schmidt MC, Pina-Oviedo S, Miranda RN. Breast implant-associated anaplastic large cell lymphoma: a review. Mod Pathol. 2019;32(2):166-188. doi:10.1038/s41379-018-0134-3 - DOI - PubMed
    1. Magnusson M, Beath K, Cooter R, et al. . The epidemiology of breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast Implants. Plast Reconstr Surg. 2019;143(5):1285-1292. doi:10.1097/PRS.0000000000005500 - DOI - PubMed
    1. de Boer M, van Leeuwen FE, Hauptmann M, et al. . Breast implants and the risk of anaplastic large-cell lymphoma in the breast. JAMA Oncol. 2018;4(3):335-341. doi:10.1001/jamaoncol.2017.4510 - DOI - PMC - PubMed
    1. Doren EL, Miranda RN, Selber JC, et al. . U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2017;139(5):1042-1050. doi:10.1097/PRS.0000000000003282 - DOI - PubMed
    1. Thomas A, Link BK, Altekruse S, Romitti PA, Schroeder MC. Primary breast lymphoma in the United States: 1975-2013. J Natl Cancer Inst. 2017;109(6). doi:10.1093/jnci/djw294 - DOI - PMC - PubMed

Publication types

MeSH terms